Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation

Emcure Pharmaceuticals Limited has announced that the United States Food and Drug Administration ("US FDA") had conducted surveillance inspection of Company's manufacturing facility located at Survey No. 485 (New), 160/P1 (Old), Kadu, Taluka - Lakhtar, District- Surendranagar, Gujarat - 382775, from October 06, 2025 to October 10, 2025. The inspection is concluded without any observation.

Shares of Emcure Pharmaceuticals Limited was last trading in BSE at Rs. 1395.75 as compared to the previous close of Rs. 1383.55. The total number of shares traded during the day was 3414 in over 475 trades.

The stock hit an intraday high of Rs. 1415.55 and intraday low of 1380.00. The net turnover during the day was Rs. 4779976.00.

Source : Equity Bulls

Keywords

EmcurePharmaceuticals INE168P01015 USFDA SurveillanceInspection ManufacturingFacility Gujarat